Psychometric Properties of the Chinese Version of the Sarcopenia and Quality of Life, a Quality of Life Questionnaire Specific for Sarcopenia
- PMID: 33991208
- DOI: 10.1007/s00223-021-00859-8
Psychometric Properties of the Chinese Version of the Sarcopenia and Quality of Life, a Quality of Life Questionnaire Specific for Sarcopenia
Abstract
A quality of life questionnaire specific to sarcopenia (SarQoL®) was successfully developed. There is a huge demand for translation and validation in Chinese. The aim of this study was to translate the SarQoL® into Chinese and investigate its psychometric properties. The translation and cross-cultural adaptation process recommended by the developers of the initial questionnaire was followed. A total of 159 participants were investigated. The translation process consists of five steps: (1) two bilinguals independently translate initial English to Chinese; (2) synthesize the two translations into one; (3) backward translations; (4) expert committee review and (5) test of the pre-final version. The validation consists of three parts: (1) validity (discriminative power, construct validity); (2) reliability (internal consistency, test-retest reliability) and (3) floor and ceiling effects. There was no difficulty in translation process. Regarding the validity, good discriminant validity {quality of life for sarcopenic subjects [35.56 (29.73-42.70)] vs. non-sarcopenic ones [73.22 (60.09-82.90)], p < 0.001} and consistent construct validity [high correlations (spearman's r) of SarQoL® with generic Short Form-36 version 2 questionnaire (0.250 to 0.824) and EuroQoL-5-Dimension questionnaire (- 0.114 to - 0.823)] were found in SarQoL®. Regarding reliability, high internal consistency (Cronbach's alpha coefficient was 0.867) and excellent test-retest reliability (intraclass coefficient correlation was 0.997, 95% CI 0.994-0.998) were found. No ceiling/floor effect was reflected. A valid SarQoL® questionnaire is now available for Chinese population. It can provide a better understanding of the sarcopenia disease burden and serve as a therapeutic outcome indicator in research.
Keywords: Chinese SarQoL®; Quality of life; Questionnaire; Sarcopenia.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
English translation and validation of the SarQoL®, a quality of life questionnaire specific for sarcopenia.Age Ageing. 2017 Mar 1;46(2):271-276. doi: 10.1093/ageing/afw192. Age Ageing. 2017. PMID: 27789428 Free PMC article.
-
Psychometric performance of the Kannada version of sarcopenia quality of life questionnaire (SarQoL®).BMC Musculoskelet Disord. 2023 Jun 2;24(1):445. doi: 10.1186/s12891-023-06559-8. BMC Musculoskelet Disord. 2023. PMID: 37268903 Free PMC article.
-
Spanish translation, cultural adaptation and validation of the SarQoL®: a specific health-related quality of life questionnaire for sarcopenia.BMC Musculoskelet Disord. 2022 Mar 1;23(1):191. doi: 10.1186/s12891-022-05125-y. BMC Musculoskelet Disord. 2022. PMID: 35232420 Free PMC article.
-
Measuring health-related quality of life in sarcopenia: summary of the SarQoL psychometric properties.Aging Clin Exp Res. 2023 Aug;35(8):1581-1593. doi: 10.1007/s40520-023-02438-3. Epub 2023 May 23. Aging Clin Exp Res. 2023. PMID: 37219755 Free PMC article. Review.
-
Current review of the SarQoL®: a health-related quality of life questionnaire specific to sarcopenia.Expert Rev Pharmacoecon Outcomes Res. 2017 Aug;17(4):335-341. doi: 10.1080/14737167.2017.1360768. Expert Rev Pharmacoecon Outcomes Res. 2017. PMID: 28749192 Review.
Cited by
-
Roles of nutrition in muscle health of community-dwelling older adults: evidence-based expert consensus from Asian Working Group for Sarcopenia.J Cachexia Sarcopenia Muscle. 2022 Jun;13(3):1653-1672. doi: 10.1002/jcsm.12981. Epub 2022 Mar 20. J Cachexia Sarcopenia Muscle. 2022. PMID: 35307982 Free PMC article. Review.
-
Content validity of SarQoL, a quality of life questionnaire specific to sarcopenia.Aging Clin Exp Res. 2024 Apr 30;36(1):101. doi: 10.1007/s40520-024-02756-0. Aging Clin Exp Res. 2024. PMID: 38710959 Free PMC article.
-
Feasibility and preliminary effects of a mindfulness-based physical exercise (MBPE) program for community-dwelling older people with sarcopenia: A protocol for a parallel, two-armed pilot randomised controlled trial.PLoS One. 2024 Apr 18;19(4):e0302235. doi: 10.1371/journal.pone.0302235. eCollection 2024. PLoS One. 2024. PMID: 38635544 Free PMC article.
-
Evaluation of the sarcopenia quality of life (SarQoL) questionnaire in community dwelling outpatient postmenopausal hungarian women.BMC Musculoskelet Disord. 2023 Apr 27;24(1):331. doi: 10.1186/s12891-023-06454-2. BMC Musculoskelet Disord. 2023. PMID: 37106363 Free PMC article.
-
Correlation study and risk assessment of lower back pain and sarcopenia.Medicine (Baltimore). 2025 May 16;104(20):e42469. doi: 10.1097/MD.0000000000042469. Medicine (Baltimore). 2025. PMID: 40388778 Free PMC article.
References
-
- Chen LK, Woo J, Assantachai P, Auyeung TW, Chou MY, Iijima K, Jang HC, Kang L, Kim M, Kim S, Kojima T, Kuzuya M, Lee JSW, Lee SY, Lee WJ, Lee Y, Liang CK, Lim JY, Lim WS, Peng LN, Sugimoto K, Tanaka T, Won CW, Yamada M, Zhang T, Akishita M, Arai H (2020) Asian working group for sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc 21(3):300-307 e302. https://doi.org/10.1016/j.jamda.2019.12.012 - DOI
-
- Phillips A, Strobl R, Vogt S, Ladwig KH, Thorand B, Grill E (2017) Sarcopenia is associated with disability status-results from the KORA-Age study. Osteoporos Int 28(7):2069–2079. https://doi.org/10.1007/s00198-017-4027-y - DOI - PubMed
-
- Tang TC, Hwang AC, Liu LK, Lee WJ, Chen LY, Wu YH, Huang CY, Hung CH, Wang CJ, Lin MH, Peng LN, Chen LK (2018) FNIH-defined sarcopenia predicts adverse outcomes among community-dwelling older people in taiwan: results from I-Lan Longitudinal Aging Study. J Gerontol A Biol Sci Med Sci 73(6):828–834. https://doi.org/10.1093/gerona/glx148 - DOI
-
- Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyere O, Cederholm T, Cooper C, Landi F, Rolland Y, Sayer AA, Schneider SM, Sieber CC, Topinkova E, Vandewoude M, Visser M, Zamboni M, Writing Group for the European Working Group on Sarcopenia in Older P, the Extended Group for E (2019) Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 48(1):16–31. https://doi.org/10.1093/ageing/afy169 - DOI
-
- Wang H, Hai S, Liu Y, Cao L, Liu Y, Liu P, Zhou J, Yang Y, Dong B (2018) Association between depressive symptoms and sarcopenia in older Chinese community-dwelling individuals. Clin Interv Aging 13:1605–1611. https://doi.org/10.2147/CIA.S173146 - DOI - PubMed - PMC
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources